"Primary Progression during Frontline CIT Associates with Decreased Efficacy of Subsequent CD 19 CAR-T Cell Therapy in LBCL." by Ariel Perez Perez

Article

Primary Progression during Frontline CIT Associates with Decreased Efficacy of Subsequent CD 19 CAR-T Cell Therapy in LBCL.

Blood Advances (2022)

Ariel Perez Perez, Baptist Health South Florida
Additional authors and institutional affiliations

Link

Disciplines

Medicine and Health Sciences

Publication Date

July, 2022

Citation Information

Ariel Perez Perez and Additional authors and institutional affiliations. "Primary Progression during Frontline CIT Associates with Decreased Efficacy of Subsequent CD 19 CAR-T Cell Therapy in LBCL." Blood Advances (2022)
Available at: http://works.bepress.com/ariel-perezperez/19/